HomeCompareAFCGV vs MRK

AFCGV vs MRK: Dividend Comparison 2026

AFCGV yields 24.39% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AFCGV wins by $38.5K in total portfolio value
10 years
AFCGV
AFCGV
● Live price
24.39%
Share price
$8.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$95.2K
Annual income
$10,505.76
Full AFCGV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AFCGV vs MRK

📍 AFCGV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAFCGVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AFCGV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AFCGV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AFCGV
Annual income on $10K today (after 15% tax)
$2,073.17/yr
After 10yr DRIP, annual income (after tax)
$8,929.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AFCGV beats the other by $601.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AFCGV + MRK for your $10,000?

AFCGV: 50%MRK: 50%
100% MRK50/50100% AFCGV
Portfolio after 10yr
$76.0K
Annual income
$10,151.95/yr
Blended yield
13.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AFCGV
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AFCGV buys
0
MRK buys
0
No recent congressional trades found for AFCGV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAFCGVMRK
Forward yield24.39%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$95.2K$56.8K
Annual income after 10y$10,505.76$9,798.13
Total dividends collected$59.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AFCGV vs MRK ($10,000, DRIP)

YearAFCGV PortfolioAFCGV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,139$2,439.02$11,206$366.19+$1.9KAFCGV
2$17,054$2,994.99$12,650$502.35+$4.4KAFCGV
3$21,881$3,633.03$14,407$694.19+$7.5KAFCGV
4$27,769$4,356.35$16,585$967.82+$11.2KAFCGV
5$34,879$5,166.94$19,342$1,363.89+$15.5KAFCGV
6$43,386$6,065.47$22,913$1,947.19+$20.5KAFCGV
7$53,475$7,051.25$27,662$2,823.89+$25.8KAFCGV
8$65,340$8,122.26$34,159$4,173.35+$31.2KAFCGV
9$79,189$9,275.24$43,337$6,308.80+$35.9KAFCGV
10$95,238$10,505.76$56,776$9,798.13+$38.5KAFCGV

AFCGV vs MRK: Complete Analysis 2026

AFCGVStock

AFC Gamma, Inc. originates, structures, underwrites, and invests in senior secured loans, and other various commercial real estate loans and debt securities for established companies operating in the cannabis industry. It primarily originates loans structured as senior loans secured by real estate, equipment, and licenses and/or other assets of the loan parties to the extent permitted by applicable laws and the regulations governing such loan parties. The company has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. AFC Gamma, Inc. was incorporated in 2020 and is based in West Palm Beach, Florida.

Full AFCGV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AFCGV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AFCGV vs SCHDAFCGV vs JEPIAFCGV vs OAFCGV vs KOAFCGV vs MAINAFCGV vs JNJAFCGV vs ABBVAFCGV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.